nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.226	1	CiPCiCtD
Betamethasone—Prednisone—prostate cancer	0.152	1	CrCtD
Betamethasone—breast cancer—Estrone—prostate cancer	0.05	0.244	CpDpCtD
Betamethasone—breast cancer—Estradiol valerate/Dienogest—prostate cancer	0.05	0.244	CpDpCtD
Betamethasone—CYP19A1—prostate cancer	0.0433	0.365	CbGaD
Betamethasone—breast cancer—Conjugated Estrogens—prostate cancer	0.0379	0.185	CpDpCtD
Betamethasone—breast cancer—Estradiol—prostate cancer	0.0379	0.185	CpDpCtD
Betamethasone—NR3C1—prostate cancer	0.0351	0.296	CbGaD
Betamethasone—breast cancer—Ethinyl Estradiol—prostate cancer	0.0287	0.14	CpDpCtD
Betamethasone—CYP3A4—prostate cancer	0.0203	0.171	CbGaD
Betamethasone—PTGS2—prostate cancer	0.0199	0.168	CbGaD
Betamethasone—Testolactone—Estrone—prostate cancer	0.0183	0.161	CrCrCtD
Betamethasone—NR3C1—Prednisone—prostate cancer	0.0101	0.105	CbGbCtD
Betamethasone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00904	0.0941	CbGbCtD
Betamethasone—ABCB1—Estramustine—prostate cancer	0.00737	0.0767	CbGbCtD
Betamethasone—PTGS2—Etoposide—prostate cancer	0.0054	0.0562	CbGbCtD
Betamethasone—ABCB1—Cabazitaxel—prostate cancer	0.00486	0.0506	CbGbCtD
Betamethasone—CYP3A4—Bicalutamide—prostate cancer	0.00475	0.0495	CbGbCtD
Betamethasone—ABCB1—Estrone—prostate cancer	0.00475	0.0494	CbGbCtD
Betamethasone—Prednicarbate—Prednisone—prostate cancer	0.00475	0.0419	CrCrCtD
Betamethasone—Testolactone—Prednisone—prostate cancer	0.00475	0.0419	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—prostate cancer	0.00461	0.0407	CrCrCtD
Betamethasone—Alclometasone—Prednisone—prostate cancer	0.00448	0.0396	CrCrCtD
Betamethasone—CYP3A4—Estramustine—prostate cancer	0.00442	0.046	CbGbCtD
Betamethasone—Budesonide—Prednisone—prostate cancer	0.00436	0.0385	CrCrCtD
Betamethasone—Amcinonide—Prednisone—prostate cancer	0.00436	0.0385	CrCrCtD
Betamethasone—Desonide—Prednisone—prostate cancer	0.00425	0.0375	CrCrCtD
Betamethasone—Diflorasone—Prednisone—prostate cancer	0.00425	0.0375	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—prostate cancer	0.00425	0.0375	CrCrCtD
Betamethasone—Flunisolide—Prednisone—prostate cancer	0.00425	0.0375	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—prostate cancer	0.00425	0.0375	CrCrCtD
Betamethasone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00423	0.0441	CbGbCtD
Betamethasone—Paramethasone—Prednisone—prostate cancer	0.00414	0.0366	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—prostate cancer	0.00404	0.0357	CrCrCtD
Betamethasone—Mometasone—Prednisone—prostate cancer	0.00395	0.0349	CrCrCtD
Betamethasone—Loteprednol—Prednisone—prostate cancer	0.00395	0.0349	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—prostate cancer	0.00395	0.0349	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—prostate cancer	0.00395	0.0349	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—prostate cancer	0.00395	0.0349	CrCrCtD
Betamethasone—CYP3A4—Abiraterone—prostate cancer	0.00394	0.041	CbGbCtD
Betamethasone—CYP3A4—Flutamide—prostate cancer	0.00394	0.041	CbGbCtD
Betamethasone—Dexamethasone—Prednisone—prostate cancer	0.00386	0.0341	CrCrCtD
Betamethasone—Rimexolone—Prednisone—prostate cancer	0.00386	0.0341	CrCrCtD
Betamethasone—Methylprednisolone—Prednisone—prostate cancer	0.00369	0.0326	CrCrCtD
Betamethasone—Prednisolone—Prednisone—prostate cancer	0.00361	0.0319	CrCrCtD
Betamethasone—Hydrocortisone—Prednisone—prostate cancer	0.00347	0.0306	CrCrCtD
Betamethasone—ABCB1—Conjugated Estrogens—prostate cancer	0.00311	0.0323	CbGbCtD
Betamethasone—CYP3A4—Cabazitaxel—prostate cancer	0.00291	0.0303	CbGbCtD
Betamethasone—CYP3A4—Estrone—prostate cancer	0.00285	0.0296	CbGbCtD
Betamethasone—ABCB1—Mitoxantrone—prostate cancer	0.00282	0.0294	CbGbCtD
Betamethasone—ABCB1—Estradiol—prostate cancer	0.00273	0.0284	CbGbCtD
Betamethasone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00254	0.0264	CbGbCtD
Betamethasone—ABCB1—Prednisone—prostate cancer	0.00235	0.0244	CbGbCtD
Betamethasone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00186	0.0194	CbGbCtD
Betamethasone—ABCB1—Etoposide—prostate cancer	0.00178	0.0185	CbGbCtD
Betamethasone—CYP3A4—Mitoxantrone—prostate cancer	0.00169	0.0176	CbGbCtD
Betamethasone—CYP3A4—Estradiol—prostate cancer	0.00163	0.017	CbGbCtD
Betamethasone—ABCB1—Docetaxel—prostate cancer	0.00163	0.017	CbGbCtD
Betamethasone—CYP19A1—semen—prostate cancer	0.00144	0.138	CbGeAlD
Betamethasone—CYP3A4—Prednisone—prostate cancer	0.00141	0.0146	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—prostate cancer	0.00121	0.0126	CbGbCtD
Betamethasone—CYP3A4—Etoposide—prostate cancer	0.00107	0.0111	CbGbCtD
Betamethasone—CYP3A4—Docetaxel—prostate cancer	0.000976	0.0102	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—prostate cancer	0.000728	0.00758	CbGbCtD
Betamethasone—NR3C1—urine—prostate cancer	0.000643	0.0617	CbGeAlD
Betamethasone—PLA2G1B—epithelium—prostate cancer	0.000639	0.0612	CbGeAlD
Betamethasone—PLA2G1B—renal system—prostate cancer	0.000592	0.0568	CbGeAlD
Betamethasone—CYP3A4—urine—prostate cancer	0.000486	0.0466	CbGeAlD
Betamethasone—NR3C2—prostate gland—prostate cancer	0.00043	0.0413	CbGeAlD
Betamethasone—PGR—prostate gland—prostate cancer	0.0004	0.0384	CbGeAlD
Betamethasone—PLA2G1B—testis—prostate cancer	0.000383	0.0367	CbGeAlD
Betamethasone—NR3C2—seminal vesicle—prostate cancer	0.000364	0.0349	CbGeAlD
Betamethasone—CYP19A1—prostate gland—prostate cancer	0.00036	0.0345	CbGeAlD
Betamethasone—PGR—epithelium—prostate cancer	0.000294	0.0282	CbGeAlD
Betamethasone—NR3C2—renal system—prostate cancer	0.000293	0.0281	CbGeAlD
Betamethasone—NR3C2—urethra—prostate cancer	0.000288	0.0276	CbGeAlD
Betamethasone—NR3C1—prostate gland—prostate cancer	0.000231	0.0221	CbGeAlD
Betamethasone—PTGS2—prostate gland—prostate cancer	0.0002	0.0192	CbGeAlD
Betamethasone—NR3C1—seminal vesicle—prostate cancer	0.000195	0.0187	CbGeAlD
Betamethasone—NR3C2—testis—prostate cancer	0.00019	0.0182	CbGeAlD
Betamethasone—PGR—testis—prostate cancer	0.000176	0.0169	CbGeAlD
Betamethasone—NR3C1—epithelium—prostate cancer	0.00017	0.0163	CbGeAlD
Betamethasone—PTGS2—seminal vesicle—prostate cancer	0.000169	0.0162	CbGeAlD
Betamethasone—CYP19A1—testis—prostate cancer	0.000159	0.0152	CbGeAlD
Betamethasone—NR3C1—renal system—prostate cancer	0.000157	0.0151	CbGeAlD
Betamethasone—NR3C1—urethra—prostate cancer	0.000155	0.0148	CbGeAlD
Betamethasone—PTGS2—epithelium—prostate cancer	0.000147	0.0141	CbGeAlD
Betamethasone—NR3C2—lymph node—prostate cancer	0.000137	0.0132	CbGeAlD
Betamethasone—PTGS2—renal system—prostate cancer	0.000136	0.0131	CbGeAlD
Betamethasone—PTGS2—urethra—prostate cancer	0.000134	0.0128	CbGeAlD
Betamethasone—PGR—lymph node—prostate cancer	0.000128	0.0122	CbGeAlD
Betamethasone—ABCB1—prostate gland—prostate cancer	0.000124	0.0118	CbGeAlD
Betamethasone—CYP3A4—renal system—prostate cancer	0.000119	0.0114	CbGeAlD
Betamethasone—NR3C1—bone marrow—prostate cancer	0.000119	0.0114	CbGeAlD
Betamethasone—CYP19A1—lymph node—prostate cancer	0.000115	0.011	CbGeAlD
Betamethasone—ABCB1—seminal vesicle—prostate cancer	0.000105	0.01	CbGeAlD
Betamethasone—PTGS2—bone marrow—prostate cancer	0.000103	0.00987	CbGeAlD
Betamethasone—NR3C1—testis—prostate cancer	0.000102	0.00975	CbGeAlD
Betamethasone—Amcinonide—ANXA1—prostate cancer	0.0001	0.0714	CrCbGaD
Betamethasone—ABCB1—epithelium—prostate cancer	9.08e-05	0.00871	CbGeAlD
Betamethasone—ABCB1—renal system—prostate cancer	8.42e-05	0.00808	CbGeAlD
Betamethasone—ABCB1—urethra—prostate cancer	8.28e-05	0.00793	CbGeAlD
Betamethasone—NR3C1—lymph node—prostate cancer	7.37e-05	0.00707	CbGeAlD
Betamethasone—PTGS2—lymph node—prostate cancer	6.38e-05	0.00612	CbGeAlD
Betamethasone—ABCB1—bone marrow—prostate cancer	6.37e-05	0.00611	CbGeAlD
Betamethasone—ABCB1—testis—prostate cancer	5.44e-05	0.00522	CbGeAlD
Betamethasone—Hydrocortisone—ANXA1—prostate cancer	4.22e-05	0.0301	CrCbGaD
Betamethasone—Testolactone—CYP19A1—prostate cancer	4.02e-05	0.0287	CrCbGaD
Betamethasone—Dexamethasone—CYP3A43—prostate cancer	3.98e-05	0.0284	CrCbGaD
Betamethasone—ABCB1—lymph node—prostate cancer	3.95e-05	0.00378	CbGeAlD
Betamethasone—Difluprednate—NR3C1—prostate cancer	3.36e-05	0.024	CrCbGaD
Betamethasone—Prednicarbate—NR3C1—prostate cancer	3.26e-05	0.0233	CrCbGaD
Betamethasone—Clocortolone—NR3C1—prostate cancer	3.26e-05	0.0233	CrCbGaD
Betamethasone—Dexamethasone—ANXA1—prostate cancer	3.14e-05	0.0224	CrCbGaD
Betamethasone—Desonide—NR3C1—prostate cancer	3.08e-05	0.022	CrCbGaD
Betamethasone—Diflorasone—NR3C1—prostate cancer	3.08e-05	0.022	CrCbGaD
Betamethasone—Desoximetasone—NR3C1—prostate cancer	3.01e-05	0.0215	CrCbGaD
Betamethasone—Loteprednol—NR3C1—prostate cancer	2.97e-05	0.0212	CrCbGaD
Betamethasone—Fludrocortisone—AR—prostate cancer	2.93e-05	0.0209	CrCbGaD
Betamethasone—Beclomethasone—CYP3A5—prostate cancer	2.81e-05	0.0201	CrCbGaD
Betamethasone—Fluoxymesterone—SHBG—prostate cancer	2.76e-05	0.0197	CrCbGaD
Betamethasone—Flurandrenolide—NR3C1—prostate cancer	2.63e-05	0.0188	CrCbGaD
Betamethasone—Flumethasone Pivalate—NR3C1—prostate cancer	2.59e-05	0.0185	CrCbGaD
Betamethasone—Halobetasol Propionate—NR3C1—prostate cancer	2.55e-05	0.0182	CrCbGaD
Betamethasone—Fluoxymesterone—AR—prostate cancer	2.42e-05	0.0173	CrCbGaD
Betamethasone—Budesonide—NR3C1—prostate cancer	2.37e-05	0.0169	CrCbGaD
Betamethasone—Amcinonide—NR3C1—prostate cancer	2.37e-05	0.0169	CrCbGaD
Betamethasone—Fluticasone furoate—NR3C1—prostate cancer	2.32e-05	0.0166	CrCbGaD
Betamethasone—Mometasone—NR3C1—prostate cancer	2.25e-05	0.0161	CrCbGaD
Betamethasone—Rimexolone—NR3C1—prostate cancer	2.23e-05	0.0159	CrCbGaD
Betamethasone—Beclomethasone—NR3C1—prostate cancer	2.1e-05	0.015	CrCbGaD
Betamethasone—Fluocinonide—NR3C1—prostate cancer	2.1e-05	0.015	CrCbGaD
Betamethasone—Alclometasone—NR3C1—prostate cancer	2.04e-05	0.0146	CrCbGaD
Betamethasone—Fluocinolone Acetonide—NR3C1—prostate cancer	2.04e-05	0.0146	CrCbGaD
Betamethasone—Fludrocortisone—NR3C1—prostate cancer	1.99e-05	0.0142	CrCbGaD
Betamethasone—Flunisolide—NR3C1—prostate cancer	1.99e-05	0.0142	CrCbGaD
Betamethasone—Clobetasol propionate—NR3C1—prostate cancer	1.99e-05	0.0142	CrCbGaD
Betamethasone—Paramethasone—NR3C1—prostate cancer	1.96e-05	0.014	CrCbGaD
Betamethasone—Fluorometholone—NR3C1—prostate cancer	1.92e-05	0.0137	CrCbGaD
Betamethasone—Fluticasone Propionate—CYP3A5—prostate cancer	1.87e-05	0.0133	CrCbGaD
Betamethasone—Fluoxymesterone—ESR1—prostate cancer	1.86e-05	0.0133	CrCbGaD
Betamethasone—Methylprednisolone—NR3C1—prostate cancer	1.85e-05	0.0132	CrCbGaD
Betamethasone—Dexamethasone—CYP17A1—prostate cancer	1.8e-05	0.0129	CrCbGaD
Betamethasone—Clobetasol propionate—CYP1A1—prostate cancer	1.8e-05	0.0129	CrCbGaD
Betamethasone—Prednisolone—CYP2A6—prostate cancer	1.69e-05	0.0121	CrCbGaD
Betamethasone—Hydrocortisone—SHBG—prostate cancer	1.68e-05	0.012	CrCbGaD
Betamethasone—Fluoxymesterone—NR3C1—prostate cancer	1.64e-05	0.0117	CrCbGaD
Betamethasone—Triamcinolone—NR3C1—prostate cancer	1.56e-05	0.0111	CrCbGaD
Betamethasone—Prednisone—NR3C1—prostate cancer	1.42e-05	0.0101	CrCbGaD
Betamethasone—Fluticasone Propionate—NR3C1—prostate cancer	1.4e-05	0.00996	CrCbGaD
Betamethasone—Budesonide—CYP3A4—prostate cancer	1.37e-05	0.0098	CrCbGaD
Betamethasone—Fluticasone furoate—CYP3A4—prostate cancer	1.35e-05	0.00961	CrCbGaD
Betamethasone—Hydrocortisone—CYP3A5—prostate cancer	1.34e-05	0.00954	CrCbGaD
Betamethasone—Prednisolone—NR3C1—prostate cancer	1.31e-05	0.00932	CrCbGaD
Betamethasone—Prednisone—CYP2C19—prostate cancer	1.29e-05	0.00921	CrCbGaD
Betamethasone—Dexamethasone—CYP1B1—prostate cancer	1.25e-05	0.00893	CrCbGaD
Betamethasone—Alclometasone—CYP3A4—prostate cancer	1.18e-05	0.00844	CrCbGaD
Betamethasone—Flunisolide—CYP3A4—prostate cancer	1.15e-05	0.00822	CrCbGaD
Betamethasone—Paramethasone—CYP3A4—prostate cancer	1.14e-05	0.00812	CrCbGaD
Betamethasone—Fluorometholone—CYP3A4—prostate cancer	1.11e-05	0.00792	CrCbGaD
Betamethasone—Diarrhoea—Estradiol—prostate cancer	1.1e-05	0.00022	CcSEcCtD
Betamethasone—Convulsion—Docetaxel—prostate cancer	1.1e-05	0.00022	CcSEcCtD
Betamethasone—Hypertension—Docetaxel—prostate cancer	1.1e-05	0.000219	CcSEcCtD
Betamethasone—Erythema—Prednisone—prostate cancer	1.1e-05	0.000219	CcSEcCtD
Betamethasone—Decreased appetite—Etoposide—prostate cancer	1.08e-05	0.000216	CcSEcCtD
Betamethasone—Myalgia—Docetaxel—prostate cancer	1.08e-05	0.000216	CcSEcCtD
Betamethasone—Loss of consciousness—Capecitabine—prostate cancer	1.08e-05	0.000216	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—prostate cancer	1.08e-05	0.000215	CcSEcCtD
Betamethasone—Asthenia—Mitoxantrone—prostate cancer	1.08e-05	0.000215	CcSEcCtD
Betamethasone—Fatigue—Etoposide—prostate cancer	1.08e-05	0.000215	CcSEcCtD
Betamethasone—Neuropathy peripheral—Epirubicin—prostate cancer	1.08e-05	0.000215	CcSEcCtD
Betamethasone—Methylprednisolone—CYP3A4—prostate cancer	1.07e-05	0.00766	CrCbGaD
Betamethasone—Pain—Etoposide—prostate cancer	1.07e-05	0.000213	CcSEcCtD
Betamethasone—Conjunctivitis—Epirubicin—prostate cancer	1.07e-05	0.000213	CcSEcCtD
Betamethasone—Dizziness—Estradiol—prostate cancer	1.06e-05	0.000212	CcSEcCtD
Betamethasone—Hypertension—Capecitabine—prostate cancer	1.06e-05	0.000212	CcSEcCtD
Betamethasone—Myalgia—Capecitabine—prostate cancer	1.05e-05	0.000209	CcSEcCtD
Betamethasone—Anxiety—Capecitabine—prostate cancer	1.04e-05	0.000208	CcSEcCtD
Betamethasone—Anaphylactic shock—Docetaxel—prostate cancer	1.04e-05	0.000207	CcSEcCtD
Betamethasone—Oedema—Docetaxel—prostate cancer	1.04e-05	0.000207	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—prostate cancer	1.04e-05	0.000207	CcSEcCtD
Betamethasone—Discomfort—Capecitabine—prostate cancer	1.03e-05	0.000207	CcSEcCtD
Betamethasone—Infection—Docetaxel—prostate cancer	1.03e-05	0.000206	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—prostate cancer	1.03e-05	0.000206	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—prostate cancer	1.03e-05	0.000205	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—prostate cancer	1.03e-05	0.000205	CcSEcCtD
Betamethasone—Diarrhoea—Mitoxantrone—prostate cancer	1.03e-05	0.000205	CcSEcCtD
Betamethasone—Vomiting—Estradiol—prostate cancer	1.02e-05	0.000204	CcSEcCtD
Betamethasone—Gastrointestinal pain—Etoposide—prostate cancer	1.02e-05	0.000204	CcSEcCtD
Betamethasone—Shock—Docetaxel—prostate cancer	1.02e-05	0.000204	CcSEcCtD
Betamethasone—Nervous system disorder—Docetaxel—prostate cancer	1.02e-05	0.000203	CcSEcCtD
Betamethasone—Ill-defined disorder—Prednisone—prostate cancer	1.02e-05	0.000203	CcSEcCtD
Betamethasone—Thrombocytopenia—Docetaxel—prostate cancer	1.02e-05	0.000203	CcSEcCtD
Betamethasone—Rash—Estradiol—prostate cancer	1.02e-05	0.000203	CcSEcCtD
Betamethasone—Dermatitis—Estradiol—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Betamethasone—Tachycardia—Docetaxel—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Betamethasone—Headache—Estradiol—prostate cancer	1.01e-05	0.000201	CcSEcCtD
Betamethasone—Oedema—Capecitabine—prostate cancer	1e-05	0.0002	CcSEcCtD
Betamethasone—Bradycardia—Epirubicin—prostate cancer	1e-05	0.0002	CcSEcCtD
Betamethasone—Angioedema—Prednisone—prostate cancer	1e-05	0.0002	CcSEcCtD
Betamethasone—Hydrocortisone—NR3C1—prostate cancer	9.98e-06	0.00713	CrCbGaD
Betamethasone—Infection—Capecitabine—prostate cancer	9.97e-06	0.000199	CcSEcCtD
Betamethasone—Dexamethasone—CYP3A5—prostate cancer	9.96e-06	0.00711	CrCbGaD
Betamethasone—Neuropathy peripheral—Doxorubicin—prostate cancer	9.95e-06	0.000199	CcSEcCtD
Betamethasone—Urticaria—Etoposide—prostate cancer	9.91e-06	0.000198	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—prostate cancer	9.9e-06	0.000197	CcSEcCtD
Betamethasone—Anorexia—Docetaxel—prostate cancer	9.89e-06	0.000197	CcSEcCtD
Betamethasone—Malaise—Prednisone—prostate cancer	9.88e-06	0.000197	CcSEcCtD
Betamethasone—Shock—Capecitabine—prostate cancer	9.88e-06	0.000197	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—prostate cancer	9.86e-06	0.000197	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—prostate cancer	9.86e-06	0.000197	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—prostate cancer	9.86e-06	0.000197	CcSEcCtD
Betamethasone—Nervous system disorder—Capecitabine—prostate cancer	9.85e-06	0.000197	CcSEcCtD
Betamethasone—Vertigo—Prednisone—prostate cancer	9.85e-06	0.000197	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—prostate cancer	9.85e-06	0.000197	CcSEcCtD
Betamethasone—Thrombocytopenia—Capecitabine—prostate cancer	9.83e-06	0.000196	CcSEcCtD
Betamethasone—Syncope—Prednisone—prostate cancer	9.83e-06	0.000196	CcSEcCtD
Betamethasone—Tachycardia—Capecitabine—prostate cancer	9.8e-06	0.000196	CcSEcCtD
Betamethasone—Hyperhidrosis—Capecitabine—prostate cancer	9.71e-06	0.000194	CcSEcCtD
Betamethasone—Hypotension—Docetaxel—prostate cancer	9.69e-06	0.000193	CcSEcCtD
Betamethasone—Dexamethasone—CYP2A6—prostate cancer	9.64e-06	0.00688	CrCbGaD
Betamethasone—Loss of consciousness—Prednisone—prostate cancer	9.63e-06	0.000192	CcSEcCtD
Betamethasone—Anorexia—Capecitabine—prostate cancer	9.57e-06	0.000191	CcSEcCtD
Betamethasone—Nausea—Estradiol—prostate cancer	9.56e-06	0.000191	CcSEcCtD
Betamethasone—Vomiting—Mitoxantrone—prostate cancer	9.54e-06	0.00019	CcSEcCtD
Betamethasone—Convulsion—Prednisone—prostate cancer	9.49e-06	0.000189	CcSEcCtD
Betamethasone—Visual impairment—Epirubicin—prostate cancer	9.49e-06	0.000189	CcSEcCtD
Betamethasone—Hypertension—Prednisone—prostate cancer	9.46e-06	0.000189	CcSEcCtD
Betamethasone—Rash—Mitoxantrone—prostate cancer	9.46e-06	0.000189	CcSEcCtD
Betamethasone—Dermatitis—Mitoxantrone—prostate cancer	9.45e-06	0.000189	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.45e-06	0.000189	CcSEcCtD
Betamethasone—Headache—Mitoxantrone—prostate cancer	9.4e-06	0.000188	CcSEcCtD
Betamethasone—Hypotension—Capecitabine—prostate cancer	9.38e-06	0.000187	CcSEcCtD
Betamethasone—Insomnia—Docetaxel—prostate cancer	9.38e-06	0.000187	CcSEcCtD
Betamethasone—Myalgia—Prednisone—prostate cancer	9.33e-06	0.000186	CcSEcCtD
Betamethasone—Paraesthesia—Docetaxel—prostate cancer	9.31e-06	0.000186	CcSEcCtD
Betamethasone—Anxiety—Prednisone—prostate cancer	9.3e-06	0.000186	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—prostate cancer	9.27e-06	0.000185	CcSEcCtD
Betamethasone—Discomfort—Prednisone—prostate cancer	9.22e-06	0.000184	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—prostate cancer	9.2e-06	0.000184	CcSEcCtD
Betamethasone—Dexamethasone—CYP19A1—prostate cancer	9.18e-06	0.00655	CrCbGaD
Betamethasone—Haemoglobin—Doxorubicin—prostate cancer	9.16e-06	0.000183	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.15e-06	0.000183	CcSEcCtD
Betamethasone—Dyspepsia—Docetaxel—prostate cancer	9.13e-06	0.000182	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—prostate cancer	9.11e-06	0.000182	CcSEcCtD
Betamethasone—Insomnia—Capecitabine—prostate cancer	9.08e-06	0.000181	CcSEcCtD
Betamethasone—Triamcinolone—CYP3A4—prostate cancer	9.05e-06	0.00646	CrCbGaD
Betamethasone—Paraesthesia—Capecitabine—prostate cancer	9.02e-06	0.00018	CcSEcCtD
Betamethasone—Decreased appetite—Docetaxel—prostate cancer	9.01e-06	0.00018	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Docetaxel—prostate cancer	8.95e-06	0.000179	CcSEcCtD
Betamethasone—Asthenia—Etoposide—prostate cancer	8.95e-06	0.000179	CcSEcCtD
Betamethasone—Oedema—Prednisone—prostate cancer	8.94e-06	0.000178	CcSEcCtD
Betamethasone—Anaphylactic shock—Prednisone—prostate cancer	8.94e-06	0.000178	CcSEcCtD
Betamethasone—Fatigue—Docetaxel—prostate cancer	8.94e-06	0.000178	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—prostate cancer	8.93e-06	0.000178	CcSEcCtD
Betamethasone—Nausea—Mitoxantrone—prostate cancer	8.91e-06	0.000178	CcSEcCtD
Betamethasone—Infection—Prednisone—prostate cancer	8.89e-06	0.000177	CcSEcCtD
Betamethasone—Pain—Docetaxel—prostate cancer	8.87e-06	0.000177	CcSEcCtD
Betamethasone—Triamcinolone—PTGS2—prostate cancer	8.86e-06	0.00632	CrCbGaD
Betamethasone—Dyspepsia—Capecitabine—prostate cancer	8.84e-06	0.000176	CcSEcCtD
Betamethasone—Pruritus—Etoposide—prostate cancer	8.83e-06	0.000176	CcSEcCtD
Betamethasone—Shock—Prednisone—prostate cancer	8.8e-06	0.000176	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—prostate cancer	8.8e-06	0.000176	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—prostate cancer	8.78e-06	0.000175	CcSEcCtD
Betamethasone—Nervous system disorder—Prednisone—prostate cancer	8.77e-06	0.000175	CcSEcCtD
Betamethasone—Tachycardia—Prednisone—prostate cancer	8.73e-06	0.000174	CcSEcCtD
Betamethasone—Decreased appetite—Capecitabine—prostate cancer	8.73e-06	0.000174	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—prostate cancer	8.7e-06	0.000174	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Capecitabine—prostate cancer	8.67e-06	0.000173	CcSEcCtD
Betamethasone—Fatigue—Capecitabine—prostate cancer	8.66e-06	0.000173	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—prostate cancer	8.65e-06	0.000173	CcSEcCtD
Betamethasone—Pain—Capecitabine—prostate cancer	8.59e-06	0.000171	CcSEcCtD
Betamethasone—Erythema—Epirubicin—prostate cancer	8.57e-06	0.000171	CcSEcCtD
Betamethasone—Feeling abnormal—Docetaxel—prostate cancer	8.55e-06	0.000171	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—prostate cancer	8.54e-06	0.00017	CcSEcCtD
Betamethasone—Anorexia—Prednisone—prostate cancer	8.53e-06	0.00017	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—prostate cancer	8.51e-06	0.00017	CcSEcCtD
Betamethasone—Gastrointestinal pain—Docetaxel—prostate cancer	8.48e-06	0.000169	CcSEcCtD
Betamethasone—Feeling abnormal—Capecitabine—prostate cancer	8.27e-06	0.000165	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—prostate cancer	8.27e-06	0.000165	CcSEcCtD
Betamethasone—Dizziness—Etoposide—prostate cancer	8.25e-06	0.000165	CcSEcCtD
Betamethasone—Gastrointestinal pain—Capecitabine—prostate cancer	8.21e-06	0.000164	CcSEcCtD
Betamethasone—Prednisone—CYP3A4—prostate cancer	8.21e-06	0.00586	CrCbGaD
Betamethasone—Abdominal pain—Docetaxel—prostate cancer	8.2e-06	0.000164	CcSEcCtD
Betamethasone—Body temperature increased—Docetaxel—prostate cancer	8.2e-06	0.000164	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Prednisone—prostate cancer	8.15e-06	0.000163	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—prostate cancer	8.14e-06	0.000162	CcSEcCtD
Betamethasone—Fluticasone Propionate—CYP3A4—prostate cancer	8.09e-06	0.00577	CrCbGaD
Betamethasone—Insomnia—Prednisone—prostate cancer	8.09e-06	0.000161	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—prostate cancer	8.05e-06	0.000161	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—prostate cancer	8.03e-06	0.00016	CcSEcCtD
Betamethasone—Urticaria—Capecitabine—prostate cancer	7.98e-06	0.000159	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—prostate cancer	7.95e-06	0.000159	CcSEcCtD
Betamethasone—Body temperature increased—Capecitabine—prostate cancer	7.94e-06	0.000158	CcSEcCtD
Betamethasone—Abdominal pain—Capecitabine—prostate cancer	7.94e-06	0.000158	CcSEcCtD
Betamethasone—Vomiting—Etoposide—prostate cancer	7.93e-06	0.000158	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—prostate cancer	7.93e-06	0.000158	CcSEcCtD
Betamethasone—Dyspepsia—Prednisone—prostate cancer	7.87e-06	0.000157	CcSEcCtD
Betamethasone—Rash—Etoposide—prostate cancer	7.87e-06	0.000157	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—prostate cancer	7.86e-06	0.000157	CcSEcCtD
Betamethasone—Headache—Etoposide—prostate cancer	7.82e-06	0.000156	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—prostate cancer	7.77e-06	0.000155	CcSEcCtD
Betamethasone—Malaise—Epirubicin—prostate cancer	7.73e-06	0.000154	CcSEcCtD
Betamethasone—Fatigue—Prednisone—prostate cancer	7.71e-06	0.000154	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—prostate cancer	7.7e-06	0.000154	CcSEcCtD
Betamethasone—Syncope—Epirubicin—prostate cancer	7.69e-06	0.000153	CcSEcCtD
Betamethasone—Prednisolone—CYP3A4—prostate cancer	7.57e-06	0.0054	CrCbGaD
Betamethasone—Loss of consciousness—Epirubicin—prostate cancer	7.53e-06	0.00015	CcSEcCtD
Betamethasone—Asthenia—Docetaxel—prostate cancer	7.44e-06	0.000149	CcSEcCtD
Betamethasone—Dexamethasone—NR3C1—prostate cancer	7.44e-06	0.00531	CrCbGaD
Betamethasone—Convulsion—Epirubicin—prostate cancer	7.43e-06	0.000148	CcSEcCtD
Betamethasone—Nausea—Etoposide—prostate cancer	7.41e-06	0.000148	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—prostate cancer	7.4e-06	0.000148	CcSEcCtD
Betamethasone—Feeling abnormal—Prednisone—prostate cancer	7.37e-06	0.000147	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—prostate cancer	7.36e-06	0.000147	CcSEcCtD
Betamethasone—Pruritus—Docetaxel—prostate cancer	7.34e-06	0.000146	CcSEcCtD
Betamethasone—Gastrointestinal pain—Prednisone—prostate cancer	7.31e-06	0.000146	CcSEcCtD
Betamethasone—Myalgia—Epirubicin—prostate cancer	7.3e-06	0.000146	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—prostate cancer	7.27e-06	0.000145	CcSEcCtD
Betamethasone—Discomfort—Epirubicin—prostate cancer	7.21e-06	0.000144	CcSEcCtD
Betamethasone—Asthenia—Capecitabine—prostate cancer	7.2e-06	0.000144	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—prostate cancer	7.15e-06	0.000143	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—prostate cancer	7.12e-06	0.000142	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—prostate cancer	7.11e-06	0.000142	CcSEcCtD
Betamethasone—Urticaria—Prednisone—prostate cancer	7.1e-06	0.000142	CcSEcCtD
Betamethasone—Pruritus—Capecitabine—prostate cancer	7.1e-06	0.000142	CcSEcCtD
Betamethasone—Diarrhoea—Docetaxel—prostate cancer	7.1e-06	0.000142	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—prostate cancer	7.07e-06	0.000141	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—prostate cancer	7.07e-06	0.000141	CcSEcCtD
Betamethasone—Anaphylactic shock—Epirubicin—prostate cancer	6.99e-06	0.00014	CcSEcCtD
Betamethasone—Oedema—Epirubicin—prostate cancer	6.99e-06	0.00014	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—prostate cancer	6.97e-06	0.000139	CcSEcCtD
Betamethasone—Infection—Epirubicin—prostate cancer	6.95e-06	0.000139	CcSEcCtD
Betamethasone—Shock—Epirubicin—prostate cancer	6.88e-06	0.000137	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—prostate cancer	6.87e-06	0.000137	CcSEcCtD
Betamethasone—Diarrhoea—Capecitabine—prostate cancer	6.87e-06	0.000137	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—prostate cancer	6.86e-06	0.000137	CcSEcCtD
Betamethasone—Dizziness—Docetaxel—prostate cancer	6.86e-06	0.000137	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—prostate cancer	6.85e-06	0.000137	CcSEcCtD
Betamethasone—Dexamethasone—CYP2E1—prostate cancer	6.85e-06	0.00489	CrCbGaD
Betamethasone—Hypertension—Doxorubicin—prostate cancer	6.85e-06	0.000137	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—prostate cancer	6.83e-06	0.000136	CcSEcCtD
Betamethasone—Dexamethasone—CYP2C19—prostate cancer	6.78e-06	0.00484	CrCbGaD
Betamethasone—Hyperhidrosis—Epirubicin—prostate cancer	6.76e-06	0.000135	CcSEcCtD
Betamethasone—Dexamethasone—CYP1A1—prostate cancer	6.76e-06	0.00482	CrCbGaD
Betamethasone—Myalgia—Doxorubicin—prostate cancer	6.75e-06	0.000135	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—prostate cancer	6.73e-06	0.000134	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—prostate cancer	6.67e-06	0.000133	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—prostate cancer	6.67e-06	0.000133	CcSEcCtD
Betamethasone—Dizziness—Capecitabine—prostate cancer	6.64e-06	0.000133	CcSEcCtD
Betamethasone—Vomiting—Docetaxel—prostate cancer	6.59e-06	0.000132	CcSEcCtD
Betamethasone—Rash—Docetaxel—prostate cancer	6.54e-06	0.000131	CcSEcCtD
Betamethasone—Hypotension—Epirubicin—prostate cancer	6.54e-06	0.00013	CcSEcCtD
Betamethasone—Dermatitis—Docetaxel—prostate cancer	6.53e-06	0.00013	CcSEcCtD
Betamethasone—Headache—Docetaxel—prostate cancer	6.5e-06	0.00013	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—prostate cancer	6.47e-06	0.000129	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—prostate cancer	6.47e-06	0.000129	CcSEcCtD
Betamethasone—Infection—Doxorubicin—prostate cancer	6.43e-06	0.000128	CcSEcCtD
Betamethasone—Asthenia—Prednisone—prostate cancer	6.42e-06	0.000128	CcSEcCtD
Betamethasone—Vomiting—Capecitabine—prostate cancer	6.38e-06	0.000127	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.37e-06	0.000127	CcSEcCtD
Betamethasone—Shock—Doxorubicin—prostate cancer	6.37e-06	0.000127	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—prostate cancer	6.35e-06	0.000127	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—prostate cancer	6.34e-06	0.000126	CcSEcCtD
Betamethasone—Rash—Capecitabine—prostate cancer	6.33e-06	0.000126	CcSEcCtD
Betamethasone—Pruritus—Prednisone—prostate cancer	6.33e-06	0.000126	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—prostate cancer	6.33e-06	0.000126	CcSEcCtD
Betamethasone—Dermatitis—Capecitabine—prostate cancer	6.32e-06	0.000126	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—prostate cancer	6.32e-06	0.000126	CcSEcCtD
Betamethasone—Headache—Capecitabine—prostate cancer	6.29e-06	0.000126	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—prostate cancer	6.28e-06	0.000125	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—prostate cancer	6.26e-06	0.000125	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—prostate cancer	6.17e-06	0.000123	CcSEcCtD
Betamethasone—Nausea—Docetaxel—prostate cancer	6.16e-06	0.000123	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—prostate cancer	6.16e-06	0.000123	CcSEcCtD
Betamethasone—Diarrhoea—Prednisone—prostate cancer	6.12e-06	0.000122	CcSEcCtD
Betamethasone—Decreased appetite—Epirubicin—prostate cancer	6.08e-06	0.000121	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—prostate cancer	6.05e-06	0.000121	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—prostate cancer	6.04e-06	0.000121	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—prostate cancer	6.03e-06	0.00012	CcSEcCtD
Betamethasone—Pain—Epirubicin—prostate cancer	5.98e-06	0.000119	CcSEcCtD
Betamethasone—Nausea—Capecitabine—prostate cancer	5.96e-06	0.000119	CcSEcCtD
Betamethasone—Dizziness—Prednisone—prostate cancer	5.91e-06	0.000118	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.9e-06	0.000118	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—prostate cancer	5.85e-06	0.000117	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—prostate cancer	5.81e-06	0.000116	CcSEcCtD
Betamethasone—Hydrocortisone—CYP3A4—prostate cancer	5.79e-06	0.00413	CrCbGaD
Betamethasone—Feeling abnormal—Epirubicin—prostate cancer	5.76e-06	0.000115	CcSEcCtD
Betamethasone—Gastrointestinal pain—Epirubicin—prostate cancer	5.72e-06	0.000114	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—prostate cancer	5.7e-06	0.000114	CcSEcCtD
Betamethasone—Vomiting—Prednisone—prostate cancer	5.69e-06	0.000113	CcSEcCtD
Betamethasone—Rash—Prednisone—prostate cancer	5.64e-06	0.000113	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—prostate cancer	5.63e-06	0.000112	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—prostate cancer	5.63e-06	0.000112	CcSEcCtD
Betamethasone—Headache—Prednisone—prostate cancer	5.6e-06	0.000112	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.59e-06	0.000112	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—prostate cancer	5.58e-06	0.000111	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—prostate cancer	5.56e-06	0.000111	CcSEcCtD
Betamethasone—Pain—Doxorubicin—prostate cancer	5.53e-06	0.00011	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—prostate cancer	5.53e-06	0.00011	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—prostate cancer	5.53e-06	0.00011	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—prostate cancer	5.33e-06	0.000106	CcSEcCtD
Betamethasone—Nausea—Prednisone—prostate cancer	5.31e-06	0.000106	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—prostate cancer	5.29e-06	0.000106	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—prostate cancer	5.14e-06	0.000103	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—prostate cancer	5.12e-06	0.000102	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—prostate cancer	5.12e-06	0.000102	CcSEcCtD
Betamethasone—Asthenia—Epirubicin—prostate cancer	5.02e-06	0.0001	CcSEcCtD
Betamethasone—Pruritus—Epirubicin—prostate cancer	4.95e-06	9.88e-05	CcSEcCtD
Betamethasone—Diarrhoea—Epirubicin—prostate cancer	4.79e-06	9.55e-05	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—prostate cancer	4.64e-06	9.27e-05	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—prostate cancer	4.63e-06	9.23e-05	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—prostate cancer	4.58e-06	9.14e-05	CcSEcCtD
Betamethasone—Vomiting—Epirubicin—prostate cancer	4.45e-06	8.88e-05	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—prostate cancer	4.43e-06	8.84e-05	CcSEcCtD
Betamethasone—Rash—Epirubicin—prostate cancer	4.41e-06	8.8e-05	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—prostate cancer	4.41e-06	8.79e-05	CcSEcCtD
Betamethasone—Headache—Epirubicin—prostate cancer	4.38e-06	8.75e-05	CcSEcCtD
Betamethasone—Dexamethasone—CYP3A4—prostate cancer	4.31e-06	0.00308	CrCbGaD
Betamethasone—Dizziness—Doxorubicin—prostate cancer	4.28e-06	8.54e-05	CcSEcCtD
Betamethasone—Dexamethasone—PTGS2—prostate cancer	4.22e-06	0.00301	CrCbGaD
Betamethasone—Nausea—Epirubicin—prostate cancer	4.15e-06	8.29e-05	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—prostate cancer	4.12e-06	8.21e-05	CcSEcCtD
Betamethasone—Rash—Doxorubicin—prostate cancer	4.08e-06	8.14e-05	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—prostate cancer	4.08e-06	8.14e-05	CcSEcCtD
Betamethasone—Headache—Doxorubicin—prostate cancer	4.05e-06	8.09e-05	CcSEcCtD
Betamethasone—Nausea—Doxorubicin—prostate cancer	3.84e-06	7.67e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism—NQO1—prostate cancer	1.43e-06	5.07e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFBR2—prostate cancer	1.42e-06	5.05e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—prostate cancer	1.42e-06	5.05e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARA—prostate cancer	1.42e-06	5.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.41e-06	5.02e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TH—prostate cancer	1.41e-06	5e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SULT2A1—prostate cancer	1.4e-06	4.98e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.4e-06	4.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ITPR1—prostate cancer	1.4e-06	4.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.4e-06	4.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP3A4—prostate cancer	1.39e-06	4.95e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MED12—prostate cancer	1.38e-06	4.89e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.37e-06	4.88e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTAP—prostate cancer	1.37e-06	4.88e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAP2K1—prostate cancer	1.37e-06	4.88e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1B1—prostate cancer	1.37e-06	4.87e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNG5—prostate cancer	1.37e-06	4.86e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—prostate cancer	1.36e-06	4.85e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SERPINE1—prostate cancer	1.35e-06	4.79e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.34e-06	4.76e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.34e-06	4.76e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAV1—prostate cancer	1.33e-06	4.74e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GGT1—prostate cancer	1.32e-06	4.71e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOA3—prostate cancer	1.31e-06	4.68e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—prostate cancer	1.31e-06	4.67e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NCOA1—prostate cancer	1.3e-06	4.64e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF2—prostate cancer	1.3e-06	4.64e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOS3—prostate cancer	1.29e-06	4.58e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP19A1—prostate cancer	1.29e-06	4.57e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LPL—prostate cancer	1.28e-06	4.56e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CREBBP—prostate cancer	1.28e-06	4.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.28e-06	4.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACSL4—prostate cancer	1.28e-06	4.54e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.27e-06	4.53e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFRB—prostate cancer	1.27e-06	4.52e-05	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—prostate cancer	1.27e-06	4.52e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HPGDS—prostate cancer	1.25e-06	4.46e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAK2—prostate cancer	1.25e-06	4.45e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2C19—prostate cancer	1.25e-06	4.43e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RXRA—prostate cancer	1.24e-06	4.41e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERCC2—prostate cancer	1.23e-06	4.37e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ARG2—prostate cancer	1.22e-06	4.35e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PHGDH—prostate cancer	1.22e-06	4.35e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UMPS—prostate cancer	1.22e-06	4.35e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MDM2—prostate cancer	1.22e-06	4.34e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—prostate cancer	1.22e-06	4.33e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ACHE—prostate cancer	1.22e-06	4.33e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—prostate cancer	1.21e-06	4.32e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.21e-06	4.29e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—prostate cancer	1.2e-06	4.28e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2A6—prostate cancer	1.2e-06	4.28e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB3—prostate cancer	1.2e-06	4.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LDHB—prostate cancer	1.2e-06	4.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR2—prostate cancer	1.2e-06	4.26e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SERPINE1—prostate cancer	1.2e-06	4.26e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—COMT—prostate cancer	1.2e-06	4.25e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—prostate cancer	1.19e-06	4.23e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—prostate cancer	1.19e-06	4.22e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.18e-06	4.2e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.18e-06	4.19e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ITPR1—prostate cancer	1.17e-06	4.16e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C3—prostate cancer	1.17e-06	4.16e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PRKACB—prostate cancer	1.16e-06	4.14e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—prostate cancer	1.15e-06	4.1e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP17A1—prostate cancer	1.15e-06	4.1e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.15e-06	4.09e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—prostate cancer	1.15e-06	4.09e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—INS—prostate cancer	1.15e-06	4.09e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—prostate cancer	1.14e-06	4.06e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.14e-06	4.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA3—prostate cancer	1.14e-06	4.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PDHA1—prostate cancer	1.14e-06	4.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UCP3—prostate cancer	1.14e-06	4.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TCN2—prostate cancer	1.14e-06	4.04e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CREBBP—prostate cancer	1.13e-06	4.01e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—prostate cancer	1.11e-06	3.96e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMS—prostate cancer	1.11e-06	3.93e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—prostate cancer	1.1e-06	3.91e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOA2—prostate cancer	1.1e-06	3.9e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—prostate cancer	1.09e-06	3.89e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—prostate cancer	1.09e-06	3.89e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—prostate cancer	1.09e-06	3.88e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.08e-06	3.86e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.08e-06	3.86e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LPL—prostate cancer	1.07e-06	3.82e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—prostate cancer	1.07e-06	3.8e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CAV1—prostate cancer	1.06e-06	3.79e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—prostate cancer	1.06e-06	3.78e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—prostate cancer	1.05e-06	3.74e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—prostate cancer	1.05e-06	3.72e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.04e-06	3.7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA4—prostate cancer	1.04e-06	3.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A1—prostate cancer	1.04e-06	3.69e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—prostate cancer	1.03e-06	3.67e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1A—prostate cancer	1.03e-06	3.66e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ERCC2—prostate cancer	1.03e-06	3.66e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—prostate cancer	1.03e-06	3.65e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2E1—prostate cancer	1.02e-06	3.64e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA2—prostate cancer	1.01e-06	3.61e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NQO1—prostate cancer	1.01e-06	3.6e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NOS3—prostate cancer	1.01e-06	3.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCG5—prostate cancer	1e-06	3.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SULT1A1—prostate cancer	1e-06	3.56e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BAD—prostate cancer	1e-06	3.56e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TH—prostate cancer	9.97e-07	3.55e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP3A4—prostate cancer	9.86e-07	3.51e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—prostate cancer	9.79e-07	3.48e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTA1—prostate cancer	9.78e-07	3.48e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1B1—prostate cancer	9.69e-07	3.45e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—prostate cancer	9.69e-07	3.45e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NAT2—prostate cancer	9.67e-07	3.44e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD3B2—prostate cancer	9.67e-07	3.44e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTO1—prostate cancer	9.67e-07	3.44e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—prostate cancer	9.66e-07	3.44e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGF—prostate cancer	9.58e-07	3.41e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS1—prostate cancer	9.58e-07	3.41e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SRC—prostate cancer	9.52e-07	3.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARA—prostate cancer	9.48e-07	3.37e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GGT1—prostate cancer	9.39e-07	3.34e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—prostate cancer	9.31e-07	3.31e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GSK3B—prostate cancer	9.3e-07	3.31e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2C18—prostate cancer	9.27e-07	3.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLCB2—prostate cancer	9.27e-07	3.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LRP2—prostate cancer	9.27e-07	3.3e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—prostate cancer	9.27e-07	3.3e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOA1—prostate cancer	9.25e-07	3.29e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—prostate cancer	9.22e-07	3.28e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—prostate cancer	9.18e-07	3.26e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—INS—prostate cancer	9.18e-07	3.26e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP19A1—prostate cancer	9.11e-07	3.24e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—prostate cancer	9.09e-07	3.24e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—P4HB—prostate cancer	9.09e-07	3.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CREBBP—prostate cancer	8.99e-07	3.2e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAV1—prostate cancer	8.91e-07	3.17e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.84e-07	3.15e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RXRA—prostate cancer	8.8e-07	3.13e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.62e-07	3.07e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAP2K1—prostate cancer	8.58e-07	3.05e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—prostate cancer	8.53e-07	3.03e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—prostate cancer	8.52e-07	3.03e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.51e-07	3.03e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—prostate cancer	8.51e-07	3.03e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MED12—prostate cancer	8.48e-07	3.02e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—COMT—prostate cancer	8.47e-07	3.01e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—prostate cancer	8.43e-07	3e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SERPINE1—prostate cancer	8.43e-07	3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNG5—prostate cancer	8.41e-07	2.99e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—prostate cancer	8.34e-07	2.97e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ITPR1—prostate cancer	8.3e-07	2.95e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF2—prostate cancer	8.16e-07	2.9e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—prostate cancer	8.12e-07	2.89e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOA3—prostate cancer	8.1e-07	2.88e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS3—prostate cancer	8.05e-07	2.86e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—prostate cancer	8.04e-07	2.86e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—prostate cancer	7.88e-07	2.8e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMS—prostate cancer	7.84e-07	2.79e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAK2—prostate cancer	7.82e-07	2.78e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—prostate cancer	7.75e-07	2.76e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HPGDS—prostate cancer	7.73e-07	2.75e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—INS—prostate cancer	7.68e-07	2.73e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.68e-07	2.73e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—prostate cancer	7.67e-07	2.73e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MDM2—prostate cancer	7.63e-07	2.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPL—prostate cancer	7.61e-07	2.71e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—prostate cancer	7.58e-07	2.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CREBBP—prostate cancer	7.53e-07	2.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—prostate cancer	7.53e-07	2.68e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—prostate cancer	7.5e-07	2.67e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACHE—prostate cancer	7.5e-07	2.67e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—prostate cancer	7.43e-07	2.64e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.41e-07	2.64e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A1—prostate cancer	7.35e-07	2.61e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ERCC2—prostate cancer	7.29e-07	2.59e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—prostate cancer	7.24e-07	2.57e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.21e-07	2.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PRKACB—prostate cancer	7.17e-07	2.55e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—prostate cancer	7.14e-07	2.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.1e-07	2.52e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—prostate cancer	7e-07	2.49e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—prostate cancer	6.97e-07	2.48e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—prostate cancer	6.85e-07	2.44e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOA2—prostate cancer	6.76e-07	2.41e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NOS3—prostate cancer	6.74e-07	2.4e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARA—prostate cancer	6.72e-07	2.39e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—prostate cancer	6.59e-07	2.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.45e-07	2.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1A—prostate cancer	6.43e-07	2.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—prostate cancer	6.42e-07	2.28e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—prostate cancer	6.41e-07	2.28e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAV1—prostate cancer	6.32e-07	2.25e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.3e-07	2.24e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NQO1—prostate cancer	6.23e-07	2.22e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—prostate cancer	6.22e-07	2.21e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TH—prostate cancer	6.14e-07	2.18e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—prostate cancer	6.12e-07	2.18e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.97e-07	2.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SRC—prostate cancer	5.95e-07	2.12e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—prostate cancer	5.91e-07	2.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GGT1—prostate cancer	5.78e-07	2.06e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—prostate cancer	5.75e-07	2.05e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—prostate cancer	5.74e-07	2.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOA1—prostate cancer	5.7e-07	2.03e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—prostate cancer	5.68e-07	2.02e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.62e-07	2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—INS—prostate cancer	5.45e-07	1.94e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RXRA—prostate cancer	5.42e-07	1.93e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—prostate cancer	5.38e-07	1.91e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CREBBP—prostate cancer	5.34e-07	1.9e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—prostate cancer	5.33e-07	1.9e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—prostate cancer	5.32e-07	1.89e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—prostate cancer	5.26e-07	1.87e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—COMT—prostate cancer	5.22e-07	1.86e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—prostate cancer	5.22e-07	1.86e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—prostate cancer	5.2e-07	1.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—prostate cancer	5.13e-07	1.82e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ITPR1—prostate cancer	5.11e-07	1.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—prostate cancer	5.06e-07	1.8e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—prostate cancer	4.93e-07	1.75e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMS—prostate cancer	4.83e-07	1.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NOS3—prostate cancer	4.78e-07	1.7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—prostate cancer	4.77e-07	1.7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPL—prostate cancer	4.69e-07	1.67e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—prostate cancer	4.64e-07	1.65e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—prostate cancer	4.53e-07	1.61e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.53e-07	1.61e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ERCC2—prostate cancer	4.49e-07	1.6e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—prostate cancer	4.41e-07	1.57e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—prostate cancer	4.37e-07	1.55e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—prostate cancer	4.22e-07	1.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARA—prostate cancer	4.14e-07	1.47e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—prostate cancer	4.01e-07	1.43e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAV1—prostate cancer	3.89e-07	1.38e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—prostate cancer	3.81e-07	1.36e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—prostate cancer	3.79e-07	1.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—prostate cancer	3.7e-07	1.32e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—prostate cancer	3.63e-07	1.29e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.55e-07	1.26e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—INS—prostate cancer	3.36e-07	1.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CREBBP—prostate cancer	3.29e-07	1.17e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.12e-07	1.11e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—prostate cancer	3.1e-07	1.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NOS3—prostate cancer	2.94e-07	1.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.72e-07	9.66e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—prostate cancer	2.69e-07	9.58e-06	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—prostate cancer	2.69e-07	9.56e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—prostate cancer	2.35e-07	8.35e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—prostate cancer	2.24e-07	7.96e-06	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—prostate cancer	2.2e-07	7.81e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.66e-07	5.89e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—prostate cancer	1.35e-07	4.81e-06	CbGpPWpGaD
